<DOC>
	<DOCNO>NCT01361425</DOCNO>
	<brief_summary>Introduction : Hypertensive emergency pregnant woman pre-eclampsia treat prevent stroke placental abruption . However , benefit antihypertensive medication maintenance remain unclear , mainly due potential risk fetal growth restriction .</brief_summary>
	<brief_title>Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia ( Metildopape )</brief_title>
	<detailed_description>Objectives : To evaluate effectiveness antihypertensive treatment maintenance 1.5 g / day methyldopa control maternal blood pressure pregnant woman severe pre-eclampsia stable blood pressure . Methods : A clinical , randomize , triple-masked , placebo-controlled study conduct Instituto de Medicina Integral Prof. Fernando Figueira March 2011 March 2012 . The study include 200 patient severe preeclampsia 20 34 week gestation , randomize two group : placebo methyldopa . Patients severe hypertensive disorder , congenital anomaly maternal medical complication condition may compromise mother-child well-being exclude study . The primary outcome : systolic , diastolic mean maternal heart rate , need association another antihypertensive agent , need reason discontinuation treatment , frequency hypertensive peak uncontrolled hypertension . The variable relate maternal characteristic pregnancy , clinical obstetric complication pregnancy delivery , adverse perinatal outcome consider secondary outcome . After inclusion patient study , number box contain methyldopa placebo offer patient appropriate explanation oral administration . The initial dose methyldopa 1.5 g / day divide three daily dos reduce 1.0 g / day increase 2.0 g / day depend clinical need patient . On group , three tablet / day placebo administer dose may reduce increase two tablet four tablet per day . Statistical analysis perform use statistical program Epi-Info 3.5.1. Minitab , version 14.2. Windows . The analysis perform group identify A B , secrecy broken obtain result prepare table resolution Committee External Monitoring . Categorical variable compare contingency table , use chi-square Fisher exact test , appropriate . Risk ratio ( RR ) 95 % confidence interval calculate measure relative risk . Regarding quantitative variable , normal distribution , comparison group perform use Student test unpaired sample . If find distribution normal , nonparametric Mann-Whitney test use .</detailed_description>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Eclampsia</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>single pregnancy severe preeclampsia life fetus stable blood pressure gestational age 20 week 34 week fetal anomaly antihypertensive drug use others drug use active labour tabagism IntraUterine Growth Restriction process</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>ultrasonography</keyword>
	<keyword>preeclampsia</keyword>
	<keyword>clinical trial</keyword>
	<keyword>treatment</keyword>
	<keyword>methyldopa</keyword>
</DOC>